Endovascular Aneurysm Repair Market Size, Share and Global Trend By Indication (Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm (TAA), Thoracoabdominal Aortic Aneurysm (TAAA)), By Age(Pediatric, Adult, Geriatric.), By Product(Percutaneous Endovascular Aneurysm Repair, Fenestrated Endovascular Aneurysm Repair, Aortic Stents & TAA Graft), By End User(Hospitals, Clinics, Ambulatory Surgery Centre) and Regional Forecast, 2024-2032

Endovascular aneurysm repair is a minimally invasive surgery performed with the help of the special stent graft commonly known as endograft. An aneurysm occurs when arteries walls are weakened, just like a balloon the artery enlarges due to the pressure of the blood beats against the walls of the weakened walls of the arteries. This endovascular repair is carried out by placing an endovascular stent graft in an aortic aneurysm.

A catheter is inserted into an artery in the upper thigh and catheter is threaded to the abdominal aorta and the stent graft is released from the catheter allowing the blood to flow through an aneurysm. Recently, Stanford healthcare, are under clinical trials of non- invasive treatment of abdominal aortic aneurysm on the increasing greatest transverse diameter of doxycycline.

The Global Endovascular Aneurysm Repair Market is expected to grow rapidly during the forecast period, owing to the increasing incidence and prevalence of abdominal aortic aneurysm disease, growth in the geriatric population, increase in the prevalence of cardiac disease and hypertension. Also increasing consumption of alcohol among the population and an increase in smoking are some of the major factors driving the growth of the global endovascular aneurysm repair market. 

However, risk of the stent movement leading to the reoccurrence of an aneurysm, congestive heart failure, inadequate reimbursement policies and the high cost of the treatment in comparison with the open surgeries performed are some of the major factors restraining the growth of the global endovascular aneurysm repair market. 

Key Players Covered 

Some of the major companies that are present in the global endovascular aneurysm repair market are Medtronic, Cook., Endologix, Inc., Lombard Medical, Inc., Cardinal Health, Abbott Laboratories., Volcano Corporation, Philips, AbbVie Inc., Bolton Medical, Scranton Gillette Communications, and others. 

SEGMENTATION  

In 2018, Abdominal aortic aneurysm dominated indication segment of the global endovascular aneurysm repair market due to attributed to the increased disease incidence. The segment is projected to continue its dominance in its market share during the forecast period. 

Key Insights 

• PESTEL Analysis


• Technological Advancement


• Pricing Analysis, Key Regions


• Reimbursement Scenario, Key Regions


• Regulatory Scenario, Key Regions


• Recent industry developments such as partnerships, mergers, and acquisitions 

Regional Analysis

North America accounted for the largest share in the global endovascular aneurysm repair market in 2018, owing to increase in a number of surgical procedures due to increasing in the incidence of the cardiac disease and hypertension among the population and a well-developed healthcare infrastructure leading to increasing demand endovascular aneurysm repair. According to the center of disease control and prevention, total 17,220 number of cases reported due to aneurysm every year in North America. Asia Pacific is expected to register comparative higher CAGR from 2019-2026 due to initiatives are taken by the several healthcare and government organization such as National Health Services (NHS), for the early diagnosis of the abdominal aneurysm and rise in number of geriatric population are some of the factors expected to drive the endovascular aneurysm repair market in the region. 

Key Industry Developments   

• In August 2018, W. L. Gore & Associates Inc. received U.S. Food and Drug Administration (FDA) for the Gore Molding & Occlusion Balloon. The polyurethane balloon catheter is designed to assist in the expansion of self-expanding stent grafts or to temporarily occlude large-diameter vessels.
• In March 2015, Lombard Medical, Inc., announced the approval for the AorFle delivery system from the Japanese Ministry of Health, Labour and Welfare.